LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 43

Search options

  1. Article ; Online: Letter to the Editor of

    Brittan, Dana / Gudzune, Kimberly A / Wickham, Edmond P / Korner, Judith

    Obesity Pillars (Online)

    2023  Volume 6, Page(s) 100064

    Language English
    Publishing date 2023-04-19
    Publishing country United States
    Document type Journal Article
    ISSN 2667-3681
    ISSN (online) 2667-3681
    DOI 10.1016/j.obpill.2023.100064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Physicians certified by the American Board of Obesity Medicine provide evidence-based care.

    Gudzune, Kimberly A / Wickham, Edmond P / Schmidt, Stacy L / Stanford, Fatima Cody

    Clinical obesity

    2020  Volume 11, Issue 1, Page(s) e12407

    Abstract: Our objective was to determine the clinical services offered by American Board of Obesity Medicine (ABOM) Diplomates and whether guideline concordant services varied by clinical practice attributes. We conducted a cross-sectional analysis of the 2019 ... ...

    Abstract Our objective was to determine the clinical services offered by American Board of Obesity Medicine (ABOM) Diplomates and whether guideline concordant services varied by clinical practice attributes. We conducted a cross-sectional analysis of the 2019 ABOM Diplomate survey (response rate 19.2%). Respondents (n = 494) self-reported services offered: nutrition, exercise, mental health, minimally invasive bariatric procedures, perioperative bariatric surgical care and FDA-approved anti-obesity medications. We graded concordance of services offered with three evidence-based obesity guidelines, and then conducted bivariate analyses comparing concordance by practice attributes. Most responding ABOM Diplomates offered nutrition (90.1%), exercise (67.8%) and mental health (76.7%). Few offered minimally invasive procedures (24.3%), and most provided perioperative surgical care (63.0%). Most (83.4%) prescribed FDA-approved medications-typically both short- and long-term agents (70.9%). Few Diplomates had low concordance with the American Heart Association/American College of Cardiology/The Obesity Society (AHA/ACC/TOS) guidelines (24.7%). Those who managed more obesity-related conditions and endorsed AHA/ACC/TOS guideline use had higher concordance with these recommendations. No differences in guideline concordance existed by population, clinical effort or location. We found similar findings regarding concordance with ) American Association of Clinical Endocrinologists/American College of Endocrinology and Obesity Medicine Association guidelines. In conclusion, most responding ABOM Diplomates offer evidence-based obesity medicine services. Clinicians may therefore have increased confidence in patient receipt of evidence-based care when referring to an ABOM Diplomate.
    MeSH term(s) American Heart Association ; Cross-Sectional Studies ; Evidence-Based Medicine ; Humans ; Obesity/therapy ; Physicians ; United States
    Language English
    Publishing date 2020-09-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 2625816-X
    ISSN 1758-8111 ; 1758-8103
    ISSN (online) 1758-8111
    ISSN 1758-8103
    DOI 10.1111/cob.12407
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control.

    Apolzan, John W / LaRose, Jessica Gokee / Anton, Stephen D / Beyl, Robbie A / Greenway, Frank L / Wickham, Edmond P / Lanoye, Autumn / Harris, Melissa N / Martin, Corby K / Bullard, Tiffany / Foster, Gary D / Cardel, Michelle I

    Nutrition & diabetes

    2023  Volume 13, Issue 1, Page(s) 3

    Abstract: Background: The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D).: Methods: This was a single arm, three-site clinical trial. ... ...

    Abstract Background: The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D).
    Methods: This was a single arm, three-site clinical trial. Participants had baseline HbA1c between 7-11% and BMI between 27-50 kg/m
    Results: Participants (n = 136) were 56.8 ± 0.8 y (Mean ± SEM), 36.9 ± 0.5 kg/m
    Conclusions: The scalable, virtually delivered T2D-tailored weight management program had favorable and clinically meaningful effects on glycemic control, body weight, and psychosocial outcomes.
    MeSH term(s) Adult ; Female ; Humans ; Male ; Blood Glucose ; Body Weight ; Diabetes Mellitus, Type 2/therapy ; Diabetes Mellitus, Type 2/complications ; Glycated Hemoglobin ; Glycemic Control ; Quality of Life ; Weight Reduction Programs
    Chemical Substances Blood Glucose ; Glycated Hemoglobin
    Language English
    Publishing date 2023-04-06
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2609314-5
    ISSN 2044-4052 ; 2044-4052
    ISSN (online) 2044-4052
    ISSN 2044-4052
    DOI 10.1038/s41387-023-00234-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The role of parents in behavioral treatment for adolescent obesity: design and rationale for the TEENS+ randomized clinical trial.

    Bean, Melanie K / LaRose, Jessica Gokee / Wickham, Edmond P / Raynor, Hollie A / Caccavale, Laura / Evans, Ronald K / Thornton, Laura M / Farthing, Sarah / Mendoza, Ashley / Mazzeo, Suzanne E

    BMC public health

    2023  Volume 23, Issue 1, Page(s) 1484

    Abstract: Background: There is an urgent need for innovative approaches to adolescent obesity treatment, particularly among individuals from racially and ethnically marginalized backgrounds, who face increased risk of obesity and its associated morbidity and ... ...

    Abstract Background: There is an urgent need for innovative approaches to adolescent obesity treatment, particularly among individuals from racially and ethnically marginalized backgrounds, who face increased risk of obesity and its associated morbidity and mortality. There is a particular dearth of research on the long-term efficacy of adolescent obesity treatments. Further, research and clinical practice guidelines consistently recommend parents' inclusion in their adolescents' obesity treatment, yet the most effective strategy to engage parents in adolescent obesity treatment remains unclear. Towards that end, this investigation will conduct a fully-powered, randomized clinical trial to examine the efficacy of two distinct approaches to involving parents in their adolescents' obesity treatment.
    Methods: Participants will be 210 12-16 year old adolescents (body mass index [BMI]≥85
    Discussion: Results of this investigation have the potential to significantly advance science in this area and ultimately inform clinical practice guidelines related to the role of parents in adolescent obesity treatment.
    Trial registration: Clinicaltrials.gov NCT03851796. Registered: February 22, 2019.
    MeSH term(s) Child ; Adolescent ; Humans ; Pediatric Obesity/prevention & control ; Body Mass Index ; Parents/education ; Behavior Therapy ; Overweight/therapy
    Language English
    Publishing date 2023-08-04
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2041338-5
    ISSN 1471-2458 ; 1471-2458
    ISSN (online) 1471-2458
    ISSN 1471-2458
    DOI 10.1186/s12889-023-16421-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.

    Fieger, Ethan I / Fadel, Kristen M / Modarres, Amir H / Wickham, Edmond P / Wolver, Susan E

    AACE clinical case reports

    2020  Volume 6, Issue 6, Page(s) e330–e333

    Abstract: Objective: We report a case of a successful reimplementation of a very low carbohydrate ketogenic diet (VLCKD) after a case of euglycemic diabetic ketoacidosis (euDKA).: Methods: A 42-year-old female with a history of type 2 diabetes mellitus on a ... ...

    Abstract Objective: We report a case of a successful reimplementation of a very low carbohydrate ketogenic diet (VLCKD) after a case of euglycemic diabetic ketoacidosis (euDKA).
    Methods: A 42-year-old female with a history of type 2 diabetes mellitus on a self-administered VLCKD was prescribed a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Two weeks after initiation, she presented with nausea and vomiting and was found to be in euDKA which was treated with fluid resuscitation, insulin infusion, and cessation of the SGLT2 inhibitor. She was discharged on insulin and instructed not to resume a VLCKD.
    Results: After discharge, the patient experienced rapid weight gain and deteriorating glycemic control and desired to resume a VLCKD. She was referred to a university-based medical weight loss clinic that specializes in a VLCKD. The patient was monitored with daily contact via the electronic health record's patient portal and serial laboratory testing while her carbohydrate intake was slowly reduced and her insulin titrated off. She has safely remained in ketosis for 2 years without a further episode of euDKA.
    Conclusion: As the clinical use of SGLT2 inhibitors and the VLCKD both become increasingly common, it is vital for practitioners to be aware that the combination can lead to euDKA. We present a case of successfully resuming a VLCKD after recovering from euDKA and cessation of SGLT2 inhibitor therapy.
    Language English
    Publishing date 2020-08-06
    Publishing country United States
    Document type Case Reports
    ISSN 2376-0605
    ISSN (online) 2376-0605
    DOI 10.4158/ACCR-2020-0314
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Insulin sensitizers in adolescents with polycystic ovary syndrome.

    LE, Trang N / Wickham, Edmond P / Nestler, John E

    Minerva pediatrica

    2017  Volume 69, Issue 5, Page(s) 434–443

    Abstract: Polycystic ovary syndrome (PCOS) is the most common disorder of androgen excess in women of reproductive age. The diagnosis of PCOS can be more challenging in adolescents than in adult women given significant overlap between normal puberty and the signs ... ...

    Abstract Polycystic ovary syndrome (PCOS) is the most common disorder of androgen excess in women of reproductive age. The diagnosis of PCOS can be more challenging in adolescents than in adult women given significant overlap between normal puberty and the signs of PCOS, including acne, menstrual irregularity, and polycystic ovarian morphology. Optimal treatments for adult women with PCOS vary depending on patient risk factors and reproductive goals, but mainly include hormonal contraception and insulin sensitizers. There is continued interest in targeting the intrinsic insulin resistance that contributes to metabolic and hormonal derangements associated with PCOS. The vast majority of published data on insulin sensitizing PCOS treatments are reported in adult women; these have included weight loss, metformin, thiazolidinediones, and the inositols. Furthermore, there is also a small but growing body of evidence in support of the use of insulin sensitizers in adolescents, with or without oral contraceptives. Discussion of the available treatments, including benefits, potential side effects, and incorporation of patient and family preferences is critical in developing a plan of care aimed at achieving patient-important improvements in PCOS signs and symptoms while addressing the longer-term cardiometabolic risks associated with the syndrome.
    Language English
    Publishing date 2017-10
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 123571-0
    ISSN 1827-1715 ; 0026-4946
    ISSN (online) 1827-1715
    ISSN 0026-4946
    DOI 10.23736/S0026-4946.17.04976-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The role of parents in behavioral treatment for adolescent obesity

    Melanie K. Bean / Jessica Gokee LaRose / Edmond P. Wickham / Hollie A. Raynor / Laura Caccavale / Ronald K. Evans / Laura M. Thornton / Sarah Farthing / Ashley Mendoza / Suzanne E. Mazzeo

    BMC Public Health, Vol 23, Iss 1, Pp 1-

    design and rationale for the TEENS+ randomized clinical trial

    2023  Volume 17

    Abstract: Abstract Background There is an urgent need for innovative approaches to adolescent obesity treatment, particularly among individuals from racially and ethnically marginalized backgrounds, who face increased risk of obesity and its associated morbidity ... ...

    Abstract Abstract Background There is an urgent need for innovative approaches to adolescent obesity treatment, particularly among individuals from racially and ethnically marginalized backgrounds, who face increased risk of obesity and its associated morbidity and mortality. There is a particular dearth of research on the long-term efficacy of adolescent obesity treatments. Further, research and clinical practice guidelines consistently recommend parents’ inclusion in their adolescents’ obesity treatment, yet the most effective strategy to engage parents in adolescent obesity treatment remains unclear. Towards that end, this investigation will conduct a fully-powered, randomized clinical trial to examine the efficacy of two distinct approaches to involving parents in their adolescents’ obesity treatment. Methods Participants will be 210 12-16 year old adolescents (body mass index [BMI]≥85th percentile) and parents (BMI≥25 kg/m2) with overweight or obesity. Dyads will be randomized to one of two 4-month treatments: 1) TEENS+Parents as Coaches (PAC), engaging parents as helpers in their child’s weight management via parent skills training based on authoritative parenting, or 2) TEENS+Parent Weight Loss (PWL), engaging parents in their own behavioral weight management. All adolescents will participate in the TEENS+ protocol, which includes nutrition education with dietary goals, supervised physical activity, and behavioral support, and integrates motivational interviewing to enhance treatment engagement. Assessments of anthropometrics, dietary intake, physical activity, parenting and home environment variables will be completed at 0, 2, 4, 8, and 12 months with the primary endpoint at 12-month follow-up. Discussion Results of this investigation have the potential to significantly advance science in this area and ultimately inform clinical practice guidelines related to the role of parents in adolescent obesity treatment. Trial registration Clinicaltrials.gov NCT03851796. Registered: February 22, 2019.
    Keywords Adolescent ; Obesity ; Parent ; Randomized clinical trial ; Public aspects of medicine ; RA1-1270
    Subject code 796
    Language English
    Publishing date 2023-08-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Evaluation and Treatment of Severe Obesity in Childhood.

    Wickham, Edmond P / DeBoer, Mark D

    Clinical pediatrics

    2015  Volume 54, Issue 10, Page(s) 929–940

    MeSH term(s) Adolescent ; Bariatric Surgery ; Child ; Child, Preschool ; Humans ; Pediatric Obesity/diagnosis ; Pediatric Obesity/drug therapy ; Pediatric Obesity/surgery ; Pediatric Obesity/therapy ; Young Adult
    Language English
    Publishing date 2015-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 207678-0
    ISSN 1938-2707 ; 0009-9228
    ISSN (online) 1938-2707
    ISSN 0009-9228
    DOI 10.1177/0009922814565886
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Thyrotropin Levels Are Associated with Cardiometabolic Risk Factors in Euthyroid Adolescents.

    Le, Trang N / Celi, Francesco S / Wickham, Edmond P

    Thyroid : official journal of the American Thyroid Association

    2016  Volume 26, Issue 10, Page(s) 1441–1449

    Abstract: Background: Increased thyrotropin (TSH) levels and free triiodothyronine to free thyroxine (fT3:fT4) ratios, even within the euthyroid range, have been associated with cardiometabolic risk factors in adults but are less characterized in youth. This ... ...

    Abstract Background: Increased thyrotropin (TSH) levels and free triiodothyronine to free thyroxine (fT3:fT4) ratios, even within the euthyroid range, have been associated with cardiometabolic risk factors in adults but are less characterized in youth. This study sought to determine relations between TSH, thyroid hormones, and cardiometabolic risk factors in euthyroid adolescents.
    Methods: Data were extracted from the United States National Health and Nutrition Examination Survey, 2007-2010, for univariate and multivariate analyses of TSH, thyroid hormones, body mass index (BMI), blood pressure, lipids, and glucose metabolism. Subjects aged 12-18 years, with normal TSH and antithyroid peroxidase antibody levels, and without a history of thyroid disease, diabetes, or treatment of hypertension/dyslipidemia (n = 1167) were included. TSH and thyroid hormones were assessed for impact on BMI Z-score, systolic blood pressure (SBP) diastolic blood pressure, total cholesterol (TC), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and glucose metabolism.
    Results: Univariate analyses revealed positive linear relations between TSH and SBP, TC, fasting and two-hour glucose, and homeostasis model assessment of insulin resistance (HOMA-IR). The fT3:fT4 ratio negatively correlated with high-density lipoprotein cholesterol but positively with BMI Z-score, SBP, triglycerides, fasting and two-hour glucose, fasting insulin, and HOMA-IR. In multivariate analyses controlling for age, sex, race/ethnicity, and BMI Z-score, relations between TSH and both TC and fasting glucose remained significant, and the fT3:fT4 ratio was positively associated with fasting glucose and HOMA-IR.
    Conclusions: In an unselected population of euthyroid U.S. adolescents, TSH and thyroid hormones correlate with multiple cardiometabolic risk factors, with age- and sex-independent effects on cholesterol and glucose metabolism.
    Language English
    Publishing date 2016-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1086044-7
    ISSN 1557-9077 ; 1050-7256
    ISSN (online) 1557-9077
    ISSN 1050-7256
    DOI 10.1089/thy.2016.0055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Response to Vorland et al's Letter to the Editor about "Impact of motivational interviewing on outcomes of an adolescent obesity treatment: Results from the MI Values randomized controlled pilot trial".

    Bean, Melanie K / Ingersoll, Karen S / Powell, Priscilla / Stern, Marilyn / Evans, Ronald K / Wickham, Edmond P / Mazzeo, Suzanne E

    Clinical obesity

    2019  Volume 9, Issue 5, Page(s) e12333

    MeSH term(s) Adolescent ; Body Mass Index ; Humans ; Motivational Interviewing ; Pediatric Obesity ; Pilot Projects
    Language English
    Publishing date 2019-08-08
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2625816-X
    ISSN 1758-8111 ; 1758-8103
    ISSN (online) 1758-8111
    ISSN 1758-8103
    DOI 10.1111/cob.12333
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top